Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-08-11

Clinical Trial Update: Glanatec(R) for Descemet Stripping in Fuch's Endothelial Dystrophy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for Glanatec in Fuchs' Endothelial Dystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glanatec

Snippet

Sponsor: Marian Macsai, MD | Conditions: Fuchs' Endothelial Dystrophy | Phase 4 | Status: RECRUITING